| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human CCL21/6Ckine (Mucin Stalk Chimera), CF |
|---|
| Description | Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 95-105 kDa, reducing conditions. MW (theoretical): 38.3 kDa. The Recombinant Human CCL21/6Ckine (Mucin Stalk Chimera) from R&D Systems is derived from NS0. The Recombinant Human CCL21/6Ckine (Mucin Stalk Chimera) has been validated for the following applications: Bioactivity. |
|---|
| Size | 25 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | 6Ckine, 6CkineSmall-inducible cytokine A21, Beta-chemokine exodus-2, chemokine (C-C motif) ligand 21, CKb9, exodus-2, member 21, SCYA21, SCYA21MGC34555, secondary lymphoid tissue chemokine, SLC, SLCSecondary lymphoid-tissue chemokine, TCA-4 |
|---|
| Gene, Accession, CAS # | CCL21, Gene ID: 6366, Accession: NP_002980 (6Ckine) & P78423 (Fractalkine Mucin-like Stalk) |
|---|
| Catalog # | 966-6C-025/CF |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human CCL21/6Ckine (Mucin Stalk Chimera), CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|